儿童和青少年心理健康预防和干预的最新进展:生物学观点

IF 0.4 Q4 PEDIATRICS

Journal of Indian Association for Child and Adolescent Mental Health Pub Date : 2023-01-01 DOI:10.1177/09731342231179832

Mansi Somaiya, Allauki Dani, Prajakta Patkar, Swati B. Shelke, M. Dave, H. Shah

{"title":"儿童和青少年心理健康预防和干预的最新进展:生物学观点","authors":"Mansi Somaiya, Allauki Dani, Prajakta Patkar, Swati B. Shelke, M. Dave, H. Shah","doi":"10.1177/09731342231179832","DOIUrl":null,"url":null,"abstract":"Psychiatric disorders in children and adolescents have a varied and heterogeneous presentation. Many risk factors play a role in the emergence of the disorder. Newer molecules have been tried for comorbidities in ASD and ADHD. Many have shown efficacy but need more robust evidence for clinical use. Oxytocin in ASD has shown efficacy however is not yet in clinical use. Viloxazine in ADHD has been FDA-approved and has shown efficacy in ADHD. Neuromodulation is tried in almost all disorders; however, studies are limited. Computer-based cognitive training has proven to be helpful in psychotic disorders. More trials are warranted to consolidate the evidence. Digital interventions and virtual reality can be a new way forward. Studies are limited.","PeriodicalId":42760,"journal":{"name":"Journal of Indian Association for Child and Adolescent Mental Health","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Recent Updates on Prevention and Intervention in Child and Adolescent Mental Health: Biological Perspective\",\"authors\":\"Mansi Somaiya, Allauki Dani, Prajakta Patkar, Swati B. Shelke, M. Dave, H. Shah\",\"doi\":\"10.1177/09731342231179832\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Psychiatric disorders in children and adolescents have a varied and heterogeneous presentation. Many risk factors play a role in the emergence of the disorder. Newer molecules have been tried for comorbidities in ASD and ADHD. Many have shown efficacy but need more robust evidence for clinical use. Oxytocin in ASD has shown efficacy however is not yet in clinical use. Viloxazine in ADHD has been FDA-approved and has shown efficacy in ADHD. Neuromodulation is tried in almost all disorders; however, studies are limited. Computer-based cognitive training has proven to be helpful in psychotic disorders. More trials are warranted to consolidate the evidence. Digital interventions and virtual reality can be a new way forward. Studies are limited.\",\"PeriodicalId\":42760,\"journal\":{\"name\":\"Journal of Indian Association for Child and Adolescent Mental Health\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Indian Association for Child and Adolescent Mental Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/09731342231179832\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Indian Association for Child and Adolescent Mental Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/09731342231179832","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}

引用次数: 0

摘要

儿童和青少年的精神障碍表现形式多样。许多危险因素在这种疾病的出现中起着一定作用。针对ASD和ADHD的合并症，已经尝试了新的分子。许多已经显示出疗效，但临床应用需要更有力的证据。催产素在ASD中已显示出疗效，但尚未在临床上使用。维洛嗪治疗多动症已经获得美国食品药品监督管理局的批准，并在多动症中显示出疗效。神经调控在几乎所有的疾病中都尝试过；然而，研究是有限的。基于计算机的认知训练已被证明对精神病有帮助。需要进行更多的审判来巩固证据。数字干预和虚拟现实可以成为一条新的前进道路。研究是有限的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Recent Updates on Prevention and Intervention in Child and Adolescent Mental Health: Biological Perspective

Psychiatric disorders in children and adolescents have a varied and heterogeneous presentation. Many risk factors play a role in the emergence of the disorder. Newer molecules have been tried for comorbidities in ASD and ADHD. Many have shown efficacy but need more robust evidence for clinical use. Oxytocin in ASD has shown efficacy however is not yet in clinical use. Viloxazine in ADHD has been FDA-approved and has shown efficacy in ADHD. Neuromodulation is tried in almost all disorders; however, studies are limited. Computer-based cognitive training has proven to be helpful in psychotic disorders. More trials are warranted to consolidate the evidence. Digital interventions and virtual reality can be a new way forward. Studies are limited.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Indian Association for Child and Adolescent Mental Health PEDIATRICS-

CiteScore

0.70

自引率

16.70%

发文量

期刊介绍： Journal of Indian Association for Child and Adolescent Mental Health (JIACAM) is a peer reviewed online journal. Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org) will be followed. JIACAM accepts original articles, review articles, case reports, conference announcements, summary of trials, letters to the editor and conference reports.